在人类质瘤细胞中通过SPHK2调节的外体miRNAs的鉴定

Jing Liu1, Huafu Zhao1, Xia Liu1

  • 1Departments of Pathology and Translational Medicine Institute, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, China.

Frontiers in oncology
|January 1, 2026
PubMed
概括

斯芬哥辛激酶2 (SPHK2) 通过调节外体微RNA (miRNA) 释放来影响质瘤的进展. SPHK2通过特定的外体介导miRNA信号通路影响M2瘤相关巨细胞 (TAM) 两极化.